Cargando…

Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature

OBJECTIVE: We conducted this meta-analysis of published data to assess the exact prognostic value of adjuvant chemotherapy-induced amenorrhea (CIA) as a prognostic factor for premenopausal breast cancer. METHODS: We searched for all relevant studies published before May 2014 in the PubMed, OVID, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiong, Yin, Wenjin, Du, Yueyao, Shen, Zhenzhou, Lu, Jingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott-Raven Publishers 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603367/ https://www.ncbi.nlm.nih.gov/pubmed/25783467 http://dx.doi.org/10.1097/GME.0000000000000440

Ejemplares similares

Chemotherapy-Induced Amenorrhea and Its Prognostic Significance in Premenopausal Women With Breast Cancer: An Updated Meta-Analysis
por: Wang, Yifei, et al.
Publicado: (2022)

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
por: Bianco, A. R., et al.
Publicado: (1991)

Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients
por: Jeon, Se Jeong, et al.
Publicado: (2016)

Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer
por: Kabirian, Rayan, et al.
Publicado: (2023)

For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
por: Zhou, Qiong, et al.
Publicado: (2014)

First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis
por: Jiang, Yiwei, et al.
Publicado: (2012)

Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
por: Shin, Jae Jun, et al.
Publicado: (2019)

Changes in ovarian function in premenopausal women with breast cancer undergoing adjuvant TC (docetaxel and cyclophosphamide) chemotherapy during a brief period of amenorrhea around the last chemotherapy cycle
por: Yoshimura, Keiko, et al.
Publicado: (2014)

Ovarian Ablation Using Goserelin Improves Survival of Premenopausal Patients with Stage II/III Hormone Receptor-Positive Breast Cancer without Chemotherapy-Induced Amenorrhea
por: Zhou, Juan, et al.
Publicado: (2015)

SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
por: Reimer, Toralf, et al.
Publicado: (2016)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
por: Du, Yueyao, et al.
Publicado: (2018)

Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrhea
por: Comim, F. V., et al.
Publicado: (2017)

Chemotherapy-induced amenorrhea in patients suffering from breast cancer in the Northwest of Iran
por: Eivazi-Ziaei, Jamal, et al.
Publicado: (2014)

Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea
por: Zhang, Bailin, et al.
Publicado: (2018)

Amenorrhea
Publicado: (1854)

Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
por: Zhou, Wen-Bin, et al.
Publicado: (2010)

Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials
por: Yin, Wenjin, et al.
Publicado: (2011)

Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer
por: Pourali, Leila, et al.
Publicado: (2013)

Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels
por: Meng, Kexin, et al.
Publicado: (2013)

A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants
por: Oktay, Kutluk H., et al.
Publicado: (2023)

The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
por: Zhou, Wenbin, et al.
Publicado: (2012)

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
por: Zhou, Liheng, et al.
Publicado: (2017)

Altered resting‐state hippocampal functional connectivity in breast cancer survivors with chemotherapy‐induced amenorrhea
por: Zhuang, Yingying, et al.
Publicado: (2023)

HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
por: Dai, Huijuan, et al.
Publicado: (2021)

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
por: Berliere, Martine, et al.
Publicado: (2008)

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990)

Feature of amenorrhea in postoperative tamoxifen users with breast cancer
por: Kim, Hoon, et al.
Publicado: (2017)

IMPACT OF BODY COMPOSITION ON THE QUALITY OF LIFE OF PREMENOPAUSAL PATIENTS WITH EARLY STAGE BREAST CANCER DURING CHEMOTHERAPY
por: Pavlović Mavić, Mirjana, et al.
Publicado: (2022)

Functional hypothalamic amenorrhea: Impact on bone and neuropsychiatric outcomes
por: Pedreira, Clarissa Carvalho, et al.
Publicado: (2022)

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
por: Turnbull, Arran K., et al.
Publicado: (2020)

An Unusual Cause of Primary Amenorrhea
por: Marenych, Nadiia, et al.
Publicado: (2021)

Epigenetics of functional hypothalamic amenorrhea
por: Fontana, L., et al.
Publicado: (2022)

Genetic polymorphisms of GGT1 gene (rs8135987, rs5751901 and rs2017869) are associated with neoadjuvant chemotherapy efficacy and toxicities in breast cancer patients
por: Sun, Lu, et al.
Publicado: (2023)

Prediction of ovarian function in premenopausal breast cancer patients with amenorrhoea after chemotherapy: a simple clinical score
por: Li, Xiao Shi, et al.
Publicado: (2016)

A Rare Case of Primary Amenorrhea with Two Etiologies, Hypothalamic Amenorrhea, Transverse Vaginal Septum, and No Hematocolpos
por: Ghaffari, Firouzeh, et al.
Publicado: (2015)

Postoperative Fever: The Potential Relationship with Prognosis in Node Negative Breast Cancer Patients
por: Yan, Tingting, et al.
Publicado: (2010)

Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles
por: Liem, Giok S., et al.
Publicado: (2015)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
por: Wu, Ziping, et al.
Publicado: (2019)

Case Report: Hypothalamic Amenorrhea Following COVID-19 Infection and Review of Literatures
por: Facondo, Paolo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h4enob0e6q4pst8qva75e8vhft